{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:27:36Z","timestamp":1780421256407,"version":"3.54.1"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Hematology Oncology Pharmacist Association Foundation"},{"name":"Division of Blood and Marrow Transplant, Department of Pediatrics, University of Minnesota"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,8,17]]},"abstract":"<jats:p>Prophylactic voriconazole use is recommended for children undergoing hematopoietic cell transplantation (HCT). Dosing considerations are essential, due to the narrow therapeutic window of voriconazole.<\/jats:p>","DOI":"10.1128\/aac.00623-21","type":"journal-article","created":{"date-parts":[[2021,6,13]],"date-time":"2021-06-13T22:38:48Z","timestamp":1623623928000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":24,"title":["CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell Transplantation"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8296-6412","authenticated-orcid":true,"given":"Takuto","family":"Takahashi","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"Division of Blood and Marrow Transplant, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam A.","family":"Mohamud","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela R.","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplant, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamala A.","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz M.","family":"Jaber","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer F.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Fisher","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3486-083X","authenticated-orcid":true,"given":"Mark N.","family":"Kirstein","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA"},{"name":"Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-007-0527-7"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2117"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/525258"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705113"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702654"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.6.2055"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2009.39"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00158"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000276"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0757-0"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.583"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00751-08"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008327537"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr517"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05761-11"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/648679"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22451"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01731-09"},{"key":"e_1_3_3_20_2","volume-title":"Vfend (voriconazole) [package insert].","author":"Pfizer","unstructured":"Pfizer. Vfend (voriconazole) [package insert]. European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vfend-epar-product-information_en.pdf. Accessed 9 February 2021."},{"key":"e_1_3_3_21_2","volume-title":"Vfend (voriconazole) [package insert].","author":"Pfizer","unstructured":"Pfizer. Vfend (voriconazole) [package insert]. The U.S. Food and Drug Administration. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021266s038,021267s047,021630s028lbl.pdf. Accessed 9 February 2021."},{"key":"e_1_3_3_22_2","first-page":"1153","volume-title":"Red Book: report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2018","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. 2018. Red Book: report of the Committee on Infectious Diseases, 31st ed, p 1153. American Academy of Pediatrics, Itasca, IL.","edition":"31"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01540-12"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra035092"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01194-17"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03023-15"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2020.1765604"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04993-14"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.2166-2172.2004"},{"key":"e_1_3_3_30_2","unstructured":"National Cancer Institute. 2017. Common terminology criteria for adverse events (CTCAE) version 5.0. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.809"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2294-5"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0173"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-015-1061-4"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2016.07.012"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.08.121"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2011.02.014"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.015511"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.665"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010395510"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1829"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.585"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645090-00005"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.23574"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19m12910"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1086\/429864"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.113"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1830"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2003.11.003"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2005.04.005"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10928-016-9487-8"},{"key":"e_1_3_3_52_2","first-page":"S84","article-title":"Simulation from ODE-based population PK\/PD and systems pharmacology models in R with mrgSolve","volume":"42","author":"Kyle T","year":"2015","unstructured":"Kyle T, Baron MRG. 2015. Simulation from ODE-based population PK\/PD and systems pharmacology models in R with mrgSolve. J Pharmacokinet Pharmacodyn 42:S84\u2013S85.","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00623-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00623-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:03:21Z","timestamp":1645484601000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00623-21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,8,17]]}},"alternative-id":["10.1128\/AAC.00623-21"],"URL":"https:\/\/doi.org\/10.1128\/aac.00623-21","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"2021-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00623-21"}}